| Date | Title | Description |
| 06.05.2026 | Venture Investors rebrands as Clarevia Ventures | After more than 40 years as Venture Investors Health Fund, the Madison-based firm has rebranded as Clarevia Ventures, reflecting what leaders describe as a more defined focus on early-stage healthcare investing.
Founded in 1984, the firm ha... |
| 09.02.2026 | What is the Wisconsin Investment Fund? | Any gathering of Wisconsin-based founders and funders will often lead to a discussion about the lack of venture capital in the Badger state. Data from the National Venture Capital Association supports this lament. In the years 2020-2024, 45... |
| 03.02.2026 | Forward BIOLABS announces first ICP awardees | Forward BIOLABS has announced the first round of awardees for its Innovation to Commercialization Pipeline (ICP) program, a new initiative designed to help early-stage biohealth companies across Wisconsin move closer to market readiness.
Th... |
| 07.11.2025 | Elephas Biosciences: $40 Million Series B-2 Raised To Advance Commercialization Of Live Tumor Profiling Platform | Elephas Biosciences has secured $40 million in Series B-2 financing to support the launch and commercialization of its Elephas Live Platform, a laboratory-developed test expected to be introduced in 2026. The company, based in Madison, Wisc... |
| 06.11.2025 | Elephas Biosciences Raises $40M in Series B-2 Funding | Elephas Biosciences, a Madison, WI-based private company that has developed a live tumor profiling platform for immunotherapy response prediction, raised $40M in Series B-2 funding.
Backers included Northpond Ventures, ARCH Venture Partners... |
| 14.09.2025 | Venture Investors Health Fund: $80 Million Closing Of Seventh Fund | Venture Investors Health Fund, one of the Midwest’s longest-standing healthcare-focused venture capital firms, has closed its seventh fund with $80 million in committed capital. The new fund will be used to invest in early-stage healthcare ... |
| 21.08.2024 | HistoSonics: A New Dawn in Non-Invasive Cancer Treatment | In the world of medical technology, innovation is the lifeblood that fuels progress. HistoSonics, a pioneer in non-invasive cancer treatment, has recently secured $102 million in Series D funding. This investment is not just a financial boo... |
| 20.08.2024 | HistoSonics: $102 Million (Series D) Raised To Scale Non-Invasive Histotripsy Platform | HistoSonics, a manufacturer of the Edison Histotripsy System and novel histotripsy therapy platforms, announced the completion of an oversubscribed $102 million Series D financing. This funding round was led by Alpha Wave Ventures, a world ... |
| 15.08.2024 | HistoSonics Secures $102M to Advance Non-Invasive Liver Tumor Treatment | What You Should Know:
– HistoSonics, a medical technology company specializing in histotripsy, a non-invasive treatment for liver tumors raises $102M in Series D financing round.
– Led by Alpha Wave Ventures, with participation from new inv... |
| 06.04.2024 | Deal Dive: EarliTec Diagnostics raises $21.5M to help diagnose autism earlier | One in 36 children in the U.S. has autism, according to the CDC. Research shows that the earlier a child gets diagnosed, the better their developmental outcome will be. EarliTec Diagnostics just raised fresh capital to expand its system tha... |
| 17.08.2023 | FemTech: Visana Health Raises $10.1M for Virtual Women’s Health Clinic | What You Should Know:
– Visana Health, a virtual-first comprehensive women’s health clinic raises $10.1M in seed funding co-led by Flare Capital Partners and Frist Cressey Ventures. The seed round also included participation from InHealth V... |
| 16.12.2021 | Reddit is—finally—going public | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox.
It’s official. Reddit announced yesterday that it had confidentially filed for an IPO with the SE... |
| 16.12.2021 | Venture Investors Health Fund announces that Shelly Lanning has joined the firm as a Venture Partner | MADISON, Wis., Dec. 15, 2021 /PRNewswire/ -- Venture Investors Health Fund, a leading early-stage health care investment firm, announced that Shelly Lanning has joined the investment team as a Venture Partner. See her bio at https://venture... |
| 12.06.2020 | EnsoData Raises $9M to Accelerate Waveform AI Platform for Clinicians | What You Should Know:
– EnsoData announces its official launch and a $9M Series A funding round to accelerate analysis and understanding of human health, starting with sleep disorder diagnoses.
– Using AI, EnsoData’s technology transforms b... |
| 28.08.2018 | Foxconn, Northwestern Mutual, Johnson Controls, Advocate Aurora Create $100M VC Fund | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Foxconn Technology Group continues to make its presence felt in the Wisconsin business community. The latest move: The Taiwanese contract manufacturer is forming a $100 millio... |
| 15.06.2018 | 30Ventures Seeks $15M to Fund Startups in Healthcare, Water Tech | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
30Ventures, one of the newest additions to Wisconsin’s venture capital scene, quietly revealed plans this week to raise up to $15 million for its debut fund, which will back h... |
| 14.05.2018 | Venture Investors To Raise As Much As $100M To Fund Health Startups | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Venture Investors plans to raise up to $100 million for a new, healthcare-focused venture capital fund, the Madison, WI-based firm said in a document recently filed with feder... |
| 12.01.2018 | SkySpecs Snags $8M to Expand Drone-Powered Turbine Inspection Service | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Drone startup SkySpecs announced this week that it has raised an $8 million Series B funding round. The investment in the Ann Arbor, MI-based company was co-led by Germany’s S... |
| 18.06.2017 | Blu Venture Investors Join $2M Seed Round For Bright Greens | Bright Greens, maker of blender-free, plant-based frozen smoothies, announced that it has raised a seed round led by eighteen94 capital, the venture capital fund of Kellogg Company. Blu Venture Investors, an early stage investment group bas... |
| 18.06.2017 | Blu Venture Investors Join $2M Seed Round For Bright Greens | Bright Greens, maker of blender-free, plant-based frozen smoothies, announced that it has raised a seed round led by eighteen94 capital, the venture capital fund of Kellogg Company. Blu Venture Investors, an early stage investment group bas... |
| 24.03.2017 | Michigan Might Hold Lessons for Improving Wisconsin’s VC Climate | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Wisconsin and Michigan share a border, but there’s a significant gap between the two states in the amount of money investors are putting into startups based there each year.
F... |
| 22.03.2017 | Investors Reboot Wisconsin Venture Capital Association | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
The Wisconsin Venture Capital Association, a nonprofit trade group that was formed in 2002 but has been dormant since 2008, is springing back to life, according to key figures... |
| 12.11.2015 | SkySpecs Takes Flight with $3 Million Series A, UpWind Partnership | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
SkySpecs, the Ann Arbor-based drone startup, announced this week that it raised $3 million in a Series A round. Venture Investors led the investment, with participation from H... |
| 09.11.2015 | Daily funding roundup - November 9, 2015 | CB Insights landed $10M; SkySpecs raised $1.15M; InnoUp Farma secured $1.5M;
CB Insights, a private company database that provides real-time information on companies, their investors, their acquirers and the industries they compete. Big thi... |
| 25.08.2015 | Daily funding roundup - August 25, 2015 | Coursera raised $49.5M; BlueData Landed $20M; Simility secured $3.45M
As we have seen so many times in recent years, with hacks on Target, Sony and the U.S. government, and now most recently on Ashley Madison, Internet security is more impo... |
| 20.05.2015 | NeuWave Medical zaps cancer with microwaves, raises $25M | Since Neuwave’s 2004 launch, it has now raised about $100 million in venture funding. The company has yet to call back to discuss what it’ll do with this latest funding round.
Previous investors have included Venture Investors, HIG BioVentu... |
| 22.07.2014 | MoneyTree Reports $121M in MI Venture Deals Last Quarter | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
Venture Capital investors had a very active second quarter of 2014, according to the latest MoneyTree report. VCs invested almost $13 billion in 1,114 U.S. startups during the... |
| 25.06.2014 | Thalchemy Raises Seed Funds to Develop Always-on Sensor Technology | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
[Updated 6/25/14, 2:26 pm. See below.] Thalchemy, a Madison, WI-based startup developing technology to facilitate continuous sensory processing in smartphones and other device... |
| 11.11.2013 | Just a little overweight? Medtech company creates nonsurgical obesity treatment for weight loss | Once the device is drained, deflated and removed, the patient continues the therapy portion of the treatment for an additional six months. The idea is the balloon jump-starts the patient into behaviors everyone already recognizes are health... |
| 08.11.2013 | MVCA Celebrates Year’s Top Deals, Names New Board Chair | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
The Michigan Venture Capital Association (MVCA) held its annual awards dinner this week to honor the year’s most important deals and VCs. During the dinner, the MVCA also name... |
| 15.07.2013 | Detroit’s UpTo Pivots, Completes a $2 Million Series A Round | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
UpTo, the Detroit-based startup that launched a social calendar app last year, announced last week that is has completed a $2 million Series A round and has pivoted to add new... |
| 16.07.2012 | Stem cell treatment for ischemia, heart failure raises enough for clinical trials | Its current funding round should last the business into 2014, he said.
Juventas’ competitors include everyone from Michigan startup Aastrom Biosciences to the Israeli public company Pluristem Therapeutics. They’re chasing a massive market. ... |
| 11.01.2011 | Wound healing firm Celleration raises $8 million | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermin... |
| 30.12.2010 | Cancer treatment company NeuWave raises $5.5 million | Wisconsin’s Venture Investors is among the investors in NeuWave.
Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and rete... |
| 09.03.2010 | Cellectar completes patient enrollment in Phase 1 cancer trial | Cellectar says the drug has the potential to treat many cancer types, including ovarian, renal and colorectal. The company is keeping its options open regarding the type of cancer it will seek to commercialize the drug for.
Last month, the ... |
| 10.02.2010 | Wisconsin radiopharmaceuticals company Cellectar raises $2.7M for cancer treatments | Based on its previous fundraising, Cellectar appears to be among Wisconsin’s most promising health care start-ups. The company raised $13 million in early 2008 to fund operations, as well as its Phase 1 trial, Wisconsin Technology News repo... |
| 13.10.2009 | Cincinnati’s Akebia Therapeutics races (as safely as possible) toward new anemia treatment | Akebia is in a race to develop its drug against other treatments supported by the likes of GlaxoSmithKline and Takeda Pharmaceuticals that are further along in their trials. The company thinks it can make up ground. Plus, even if it isn’t f... |
| 29.07.2009 | Cardiovascular biopharma Akebia takes additional funding to develop 2 drugs | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 14.07.2009 | Ohio biotech industry celebrates state incentives left intact | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 08.07.2009 | NanoBio adds another $10 million to fund company through 2011 | Promoted
Covid-19’s terrible toll on diabetes patients. What can be done?
The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 30.06.2009 | Oncology drugmaker ProCertus closes on $2.1 million | Promoted
Clinical Care Capacity Planning
Learn how to manage clinical care capacity more efficiently during uncertain times.
SAP
Promoted
Telemedicine’s potential to provide healthcare to the world’s most vulnerable
Teladoc Health Head of R... |
| 19.07.2007 | Venture Investors raises $115m fund | US Midwest-focused early stage venture capital firm Venture Investors has closed its fourth fund, Venture Investors Earl |
| 11.05.2007 | ProCertus pulls in $2.3M for prevention of chemo, radiation side effects | ProCertus BioPharm, a Madison, Wis., company developing drugs to minimize the side effects of radiation and chemotherapy, raised $2.3 million in a first round of financing. The company will use the money to begin human tests of products suc... |
| 09.05.2007 | TomoTherapy, cancer-treatment system maker, gets enthusiastic IPO reception | TomoTherapy, a Madison, Wis.-based maker of imaging and radiation-treatment systems for cancer therapy, raised $222.3 million in an initial offering after its shares priced higher than the company’s original range.
TomoTherapy shares, which... |
| - | Wound healing firm Celleration raises $8 million | Eden Prairie-based Celleration has raised $8 million in Series E stock toward more sales and marketing resources for its mist therapy wound healing product.
CEO Mark Wagner, who joined the company in 2009, said by phone that Celleration att... |
| - | Stem cell treatment for ischemia, heart failure raises enough for clinical trials | The regenerative medicine company Juventas Therapeutics, which had already said it added Takeda Pharmaceuticals to its roster of investors, said this weekend it has raised enough money to take its treatments for heart failure and a severe f... |
| - | Cardiovascular biopharma Akebia takes additional funding to develop 2 drugs | CINCINNATI, Ohio — Cardiovascular drugmaker Akebia Therapeutics will add $10 million more than expected to its Series A fund-raise, bringing the total to $25 million, the company stated (pdf).
The company stated it raised additional money t... |
| - | Ohio biotech industry celebrates state incentives left intact | COLUMBUS, Ohio — While health-care providers were suffering, economic development officials in the medical industry said Ohio’s budget positioned them to take advantage of other states’ cutbacks.
Ohio left the Technology Investment Tax Cre... |
| - | Cincinnati’s Akebia Therapeutics races (as safely as possible) toward new anemia treatment | CINCINNATI, Ohio — As Procter & Gamble started the slow dismantling of its pharmaceutical division three years ago, Akebia Therapeutics was there to pick up some pieces.
At that time, Akebia was largely Joseph Gardner –Â who was leaving... |
| - | Cellectar completes patient enrollment in Phase 1 cancer trial | Radiopharmaceuticals company Cellectar Inc. has enrolled the last of eight patients in a Phase 1 trial of its cancer-treating drug candidate.
The trial is designed to measure drug safety and dosimetry of Cellectar’s lead compound, called CL... |
| - | NanoBio adds another $10 million to fund company through 2011 | ANN ARBOR, Michigan — NanoBio has landed an additional $10 million investment that brings the Michigan biopharmaceutical company closer to its first licensing deal and an over-the-counter product.
John Coffey, NanoBio’s vice president for b... |
| - | Oncology drugmaker ProCertus closes on $2.1 million | MADISON, Wisconsin — ProCertus BioPharm will use $2.1 million in private investment to start several clinical trials on drugs that fight the side effects of radiotherapy and chemotherapy.
The oncology drugmaker also said Tuesday it has star... |
| - | Cancer treatment company NeuWave raises $5.5 million | The Wisconsin medical device company NeuWave Medical has raised more than $5.5 million ahead of its sales efforts for a cancer treatment that recently won federal approval, according to regulatory filings.
The U.S. Food and Drug Administrat... |
| - | Wisconsin radiopharmaceuticals company Cellectar raises $2.7M for cancer treatments | MADISON, Wisconsin — Cellectar Inc. has raised $2.7 million for its radiopharmaceutical technology that treats and detects a variety of cancers, according to a Securities and Exchange Commission filing.
Cellectar’s lead compound, called CLR... |
| - | NeuWave Medical zaps cancer with microwaves, raises $25M | Wisconsin device-maker Neuwave Medical just raised a $25 million equity round from 38 investors, according to a regulatory filing.
The company has a whole suite of cancer ablation tools, and many of which have received FDA approval. They us... |
| - | Just a little overweight? Medtech company creates nonsurgical obesity treatment for weight loss | As we approach the holidays, many of us are looking at shopping catalogs, plates full of cookies and expanding waistlines. A California healthcare startup has an obesity treatment that could provide non-surgical weight loss to patients who ... |
